These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 9777922)
1. Combination therapy for early Alzheimer's disease: what are we waiting for? Doraiswamy PM; Steffens DC J Am Geriatr Soc; 1998 Oct; 46(10):1322-4. PubMed ID: 9777922 [TBL] [Abstract][Full Text] [Related]
2. Current approaches to the pharmacological treatment of Alzheimer's disease. Tan EC; Hilmer SN; Garcia-Ptacek S; Bell JS Aust J Gen Pract; 2018 Sep; 47(9):586-592. PubMed ID: 30244564 [TBL] [Abstract][Full Text] [Related]
3. Combination drug therapy for Alzheimer's disease: what is evidence-based, and what is not? Xiong G; Doraiswamy PM Geriatrics; 2005 Jun; 60(6):22-6. PubMed ID: 15948662 [TBL] [Abstract][Full Text] [Related]
8. Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study. Canevelli M; Adali N; Kelaiditi E; Cantet C; Ousset PJ; Cesari M; Phytomedicine; 2014 May; 21(6):888-92. PubMed ID: 24548724 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington. Davis KL Geriatrics; 1999 Feb; 54(2):42-7; quiz 48. PubMed ID: 10024872 [TBL] [Abstract][Full Text] [Related]
10. Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs. Grundman M; Corey-Bloom J; Thal LJ J Neural Transm Suppl; 1998; 53():255-75. PubMed ID: 9700663 [TBL] [Abstract][Full Text] [Related]
11. Current and future treatments for cognitive deficits in dementia. McLendon BM; Chen GG; Doraiswamy PM Curr Psychiatry Rep; 2000 Feb; 2(1):20-3. PubMed ID: 11122927 [TBL] [Abstract][Full Text] [Related]
12. Part VI. Primary drug therapies for Alzheimer's disease. Knopman DS Dis Mon; 2000 Nov; 46(11):745-60. PubMed ID: 11130325 [No Abstract] [Full Text] [Related]
13. Combination drug therapies for AD: progress is slow, but we must keep trying. Farlow MR Geriatrics; 2005 Jun; 60(6):13-4. PubMed ID: 15948660 [No Abstract] [Full Text] [Related]
14. Combination therapy in Alzheimer's disease: a review of current evidence. Schmitt B; Bernhardt T; Moeller HJ; Heuser I; Frölich L CNS Drugs; 2004; 18(13):827-44. PubMed ID: 15521788 [TBL] [Abstract][Full Text] [Related]
15. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council. Fillit H; Cummings J Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691 [TBL] [Abstract][Full Text] [Related]
16. Treatment of Alzheimer's disease. New developments. Giacobini E; Michel JP Ann Med Interne (Paris); 1998 Jun; 149(4):231-7. PubMed ID: 11490551 [TBL] [Abstract][Full Text] [Related]
17. Cognitive enhancement therapy for Alzheimer's disease. The way forward. Parnetti L; Senin U; Mecocci P Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864 [TBL] [Abstract][Full Text] [Related]
18. Treatment options for Alzheimer's disease. Dinsmore ST J Am Osteopath Assoc; 1999 Sep; 99(9 Suppl):S6-8. PubMed ID: 10730506 [TBL] [Abstract][Full Text] [Related]